Lack of association between lymphotoxin-α, galectin-2 polymorphisms and coronary artery disease: A meta-analysis

Atherosclerosis

Volumn 208, Issue 2, 2010, Pages 433-436

  Li, Wenlong ^a   Xu, Jing ^a   Wang, Xiaojian ^a   Chen, Jingzhou ^a   Zhang, Channa ^a   Sun, Kai ^a   Hui, Rutai ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Coronary artery disease; Galectin 2; Lymphotoxin ; Meta analysis; Myocardial infarction

Indexed keywords

GALECTIN 2; LYMPHOTOXIN;

ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA EXTRACTION; DISEASE MODEL; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

ALLELES; CORONARY ARTERY DISEASE; FEMALE; GALECTIN 2; GENES, DOMINANT; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOTOXIN-ALPHA; MALE; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 75049083845     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.08.014     Document Type: Article

References (32)

1. Libby P. Molecular bases of the acute coronary syndromes. Circulation 91 (1995) 2844-2850
2. Ozaki K., Ohnishi Y., Iida A., et al. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32 (2002) 650-654
3. Ozaki K., Inoue K., Sato H., et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 429 (2004) 72-75
4. Koch W., Hoppmann P., Michou E., et al. Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans. Hum Mol Genet 16 (2007) 1821-1827
5. Mangino M., Braund P., Singh R., et al. LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians. Atherosclerosis 194 (2007) 112-115
6. Ryan A.W., O'Brien E., Shields D., and McManus R. Lack of association between NFKBIL1/LTA polymorphisms and hypertension, myocardial infarct, unstable angina and stable angina in a large Irish population sample. Atherosclerosis 197 (2008) 465-466
7. Sedlacek K., Neureuther K., Mueller J.C., et al. Lymphotoxin-alpha and galectin-2 SNPs are not associated with myocardial infarction in two different German populations. J Mol Med 85 (2007) 997-1004
8. Higgins J.P., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
9. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
10. Koch W., Kastrati A., Bottiger C., et al. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 159 (2001) 137-144
11. Asselbergs F.W., Pai J.K., Rexrode K.M., Hunter D.J., and Rimm E.B. Effects of lymphotoxin-alpha gene and galectin-2 gene polymorphisms on inflammatory biomarkers, cellular adhesion molecules and risk of coronary heart disease. Clin Sci (Lond) 112 (2007) 291-298
12. Braun J., Marz W., Winkelmann B.R., et al. Tumour necrosis factor beta alleles and hyperinsulinaemia in coronary artery disease. Eur J Clin Invest 28 (1998) 538-542
13. Chen Z.Q., Zhen Z.F., Ma J.F., et al. Study of tumor necrosis factor and its gene polymorphism in old patients with coronary heart disease. Clin J Ceriatr Cardiovasc Cerebrovasc Dis 3 (2001) 156-158
14. Clarke R., Xu P., Bennett D., et al. Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet 2 (2006) e107
15. Du Z.M., Huang A.L., and Liu X.H. The relationship between coronary heart disease and tumor necrosis factor-beta polymorphisms. J Modern Clin Med Bioeng 10 (2004) 483-484
16. Gao H.X., Zhang Z., Zhang J., et al. Association of lymphotoxin alpha NcoI gene polymorphism and the genetic predisposition of coronary heart disease. Mol Cardiol China 9 (2009) 34-37
17. Iwanaga Y., Ono K., Takagi S., et al. Association analysis between polymorphisms of the lymphotoxin-alpha gene and myocardial infarction in a Japanese population. Atherosclerosis 172 (2004) 197-198
18. Kimura A., Takahashi M., Choi B.Y., et al. Lack of association between LTA and LGALS2 polymorphisms and myocardial infarction in Japanese and Korean populations. Tissue Antigens 69 (2007) 265-269
19. Li Y., Wang M., Zhang P.A., et al. Association between tumor necrosis factor-beta polymorphisms and coronary heart disease in a Chinese population. Chin J Med Genet 21 (2004) 583-586
20. Morgan T.M., Krumholz H.M., Lifton R.P., and Spertus J.A. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 297 (2007) 1551-1561
21. Padovani J.C., Pazin-Filho A., Simoes M.V., et al. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 100 (2000) 263-269
22. Tobin M.D., Braund P.S., Burton P.R., et al. Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J 25 (2004) 459-467
23. Yamada A., Ichihara S., Murase Y., et al. Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in Japanese. J Mol Med 82 (2004) 477-483
24. Zhao W.Q., Wang J., Xie H.Z., et al. Association between genetic variation of lymphotoxin-alpha 804C/A and susceptibility, lesion severity and molecular markers of coronary heart disease. Chin J Cardio Med 13 (2008) 17-20
25. Zhu J.H., Li H.M., Ju S.Q., et al. Relationship of tumor necrosis factor-beta polymorphism with coronary heart disease. Acta Acad Med Nantong 22 (2002) 382-386
26. Park S., Youn J.C., Shin D.J., et al. Genetic polymorphism in the pregnancy-associated plasma protein-A associated with acute myocardial infarction. Coron Artery Dis 18 (2007) 417-422
27. Panoulas V.F., Nikas S.N., Smith J.P., et al. Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis. Ann Rheum Dis 67 (2008) 1550-1556
28. Schreyer S.A., Vick C.M., and LeBoeuf R.C. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J Biol Chem 277 (2002) 12364-12368
29. Laxton R., Pearce E., Kyriakou T., and Ye S. Association of the lymphotoxin-alpha gene Thr26Asn polymorphism with severity of coronary atherosclerosis. Genes Immun 6 (2005) 539-541
30. Mizuno H., Sato H., Sakata Y., et al. Impact of atherosclerosis-related gene polymorphisms on mortality and recurrent events after myocardial infarction. Atherosclerosis 185 (2006) 400-405
31. Wang X., Cheng S., Brophy V.H., et al. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke 40 (2009) 683-695
32. Tanne D., Haim M., Boyko V., et al. Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort. Stroke 33 (2002) 2182-2186